fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ESC Report 2014: Long-term efficacy and safety of alirocumab for lowering cholesterol

Written by | 16 Sep 2014

Report from the ESC Annual Congress by Bruce Sylvester: The investigational monoclonal antibody alirocumab, which significantly lowers cholesterol on top of regular statin therapy, also lowers the incidence… read more.

ASCO Report 2014: The evolution of our molecular understanding of Colorectal Cancer

Written by | 4 Sep 2014

What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London.  At… read more.

FDA Highlights: Letrozole aids births in women with PCOS

Written by | 28 Aug 2014

by Bruce Sylvester: Estrogen blocking letrozole treatment results in higher birth rates in women with polycystic ovary syndrome (PCOS) than standard-therapy clomiphane, researchers reported on July 9, 2014… read more.

Naloxone counteracts constipation and as an abuse deterrent.

Written by | 14 Aug 2014

Opioids are widely prescribed to patients experiencing chronic severe pain. While these drugs are very effective for treating and managing pain, they have one particularly bothersome side effect:… read more.

FDA Highlights: ED drugs could help boys with duchenne muscular dystrophy

Written by | 18 Jul 2014

by Bruce Sylvester – Treatment with tadalafil or sidenafil appears to improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to research published in… read more.

EMA Highlights: Green light for new medicines

Written by | 16 Jul 2014

by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.

New tick-borne disease threatens immunosuppressed patients

Written by | 8 Jul 2014

World Health Matters: Sweden by Gary Finnegan – A newly discovered tick-borne bacterium known as Candidatus Neoehrlichia mikurensis has been implicated in six cases of disease in Sweden…. read more.

Botox treatment lifts depression in half of study patients

Written by | 19 May 2014

Emerging uses of FDA approved drugs – by Bruce Sylvester – Over half of depressed subjects in a newly reported study who were injected with onabotulinumtoxinA (OBA/Botox) achieved… read more.

Eplerenone lowers mortality following Acute Myocardial Infarction

Written by | 16 May 2014

by Bruce Sylvester – Emerging uses of FDA approved drugs – Eplerenone,  a drug used to reduce the risk of death in patients with heart failure, shows significant… read more.

Immunosuppressants might aid fight against persistent HIV infection

Written by | 15 May 2014

by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.

Acetazolamide improves vision loss in idiopathic intracranial hypertension

Written by | 15 May 2014

by Bruce Sylvester – Emerging uses of FDA-approved drugs – Treatment with acetazolamide plus a low-sodium weight-reduction diet for patients diagnosed with idiopathic intracranial hypertension (IIH)mand mild vision… read more.

Less dietary salt linked to drop in cardiovascular disease death in past ten years

Written by | 14 May 2014

by Bruce Sylvester – A 15% drop in dietary salt use from 2003-2011 in England and a 40% drop in deaths from heart disease and stroke during the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.